Navigation Links
Stenum Hospital Kicks off International Rollout of M6 Artificial Lumbar Disc Replacement Surgery
Date:11/4/2009

Stenum Hospital announced the successful rollout of the first international patients to receive the Spinal Kinetics M6-L artificial lumbar disc, and the commencement of the implants full availability at the clinic. Four American patients received M6-L implants, one single level, two double level, and one three level intervention, 8 total implants. All patients are doing well.

Bremen, Germany (PRWEB) November 4, 2009 -- Leading spine center Stenum Hospital announced the successful rollout of the first international patients to receive the Spinal Kinetics M6-L artificial lumbar disc, and the commencement of the implants full availability at the clinic. Four American patients received M6-L implants, one single level, two double level, and one three level intervention, 8 total implants. All patients are doing well.
The M6-L artificial disc represents Stenum Hospitals continued international dominance in the non-fusion, motion preservation market for solutions for degenerative diseases of the spine. Stenum Hospital launched the M6-C artificial cervical disc three years ago. To date, over 3,000 M6 discs have been implanted. Like the M6-C, the M6-L lumbar disc is an advanced generation artificial disc developed to replace an inter-vertebral disc damaged by disc degeneration. It is the only replacement disc that replicates the anatomic structure of a natural lumbar disc by incorporating an artificial nucleus and annulus. Together, the nucleus and annulus are designed to provide the same motion characteristics of a natural disc.

The M6-L's compressible polymer nucleus is designed to simulate the function of the native nucleus, while the surrounding multi-layer high tensile strength fiber annulus is intended to facilitate a controlled range of motion in multiple directions. The M6 artificial disc is implanted with proprietary surgical instrumentation. This specialized system was designed wi
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. New research explores newborn in-hospital weight loss
2. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
3. Norwalk virus: Cruise ship illness challenging and costly to hospitals, too
4. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
5. Billy Graham Home After Hospitalization:
6. Alvarado Hospital Files Countersuit Against Blue Shield
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
9. Annual flu shot cuts need for doctors visits, hospitalization among children
10. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
11. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... WEDNESDAY, May 23 (HealthDay News) -- The use ... reduced through a multi-pronged approach that includes more ... relatives, according to a new German study. ... ineffective, physical restraints such as bed rails and ... A recent survey found that the rate of ...
(Date:5/23/2012)... Prior treatment with inhaled corticosteroids in patients with ... is associated with a lower incidence and severity ... from researchers in Spain. , A parapneumonic effusion ... that accumulates between the two pleural layers, the ... as a result of a pneumonia, lung abscess, ...
(Date:5/23/2012)... Researchers in the United Kingdom have determined ... anti-inflammatory properties, can be an effective treatment option ... a life-threatening complication that occurs in the majority ... is the leading cause of mortality after the ... when the body repeatedly rejects the transplanted lung ...
(Date:5/22/2012)... Magnetic resonance imaging (MRI) provides an indication ... significantly earlier than possible through clinical examination, according ... journal Radiology . , Women with ... Research has shown that women who receive this ... to achieve breast conservation than those receiving chemotherapy ...
(Date:5/22/2012)... Large randomized controlled trials (RCTs) are critical for ... Yet Canada provides scant support for these studies ... in CMAJ ( Canadian Medical Association ... and Hamilton Health Sciences, Hamilton, Ontario, with Dr. ... the analysis and appendix that Canada should provide ...
Breaking Medicine News(10 mins):Health News:Study Offers Ways to Decrease Use of Restraints at Nursing Homes 2Health News:Long-term ICS use reduces pleural effusion in patients with CAP 2Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Breast MRI helps predict chemotherapy's effectiveness 2Health News:Canada should significantly increase its funding of randomized clinical trials 2
... company WorldMed Assist says economic downturn has created an uptick in his ... benefit plans that have been dramatically scaled back. , ... Concord, CA ... there were many predictions how this would play out for the young ...
... Dr. Jane L. Delgado, President and CEO ... leading Hispanic health advocacy group, released the following statement ... and Tobacco Control Act, which will provide the Food ... products. "Fifteen years ago Congressman Waxman summoned the ...
... President Obama,s economic stimulus package encourages the use ... this area of healthcare reform to become a reality, ... providers.See video from Siemens (NYSE: SI ) ... Information technology (IT), or the sharing of ...
... fruit, combined with contraceptive pill and a genetic mutation, ... April 2 (HealthDay News) -- A rare set of ... genetic mutation almost cost a 42-year-old woman her leg, ... in the car one afternoon," said Dr. Lucinda Grande, ...
... sports athletesGOLDEN VALLEY, Minn., April 2 ... a history of developing talented, nationally and internationally recognized ... rugby. On Thursday, April 9, at 6 p.m., three ... intent in the Gym at Courage Center Golden Valley. ...
... around us, images flicker into our brains ,like so many ... our eyes move, which is several times a second. Yet ... display. , Why not? , Neuroscientists at The Johns Hopkins ... special region of the brain,s visual cortex ,which is in ...
Other Medicine News:Health News:Economic Turmoil Creates Boom for Medical Tourism 2Health News:Economic Turmoil Creates Boom for Medical Tourism 3Health News:Economic Turmoil Creates Boom for Medical Tourism 4Health News:National Alliance for Hispanic Health Statement on Passage of Bill Granting FDA Authority to Regulate Tobacco 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 2Health News:Grapefruit-Heavy Diet Helped Spur Dangerous Clot 3Health News:Courage Center Hosts College Scholarship Signing Ceremony Thursday, April 9, 2009 2Health News:JHU researcher discovers brain cells have 'memory' 2Health News:JHU researcher discovers brain cells have 'memory' 3
(Date:5/23/2012)... Tactile, Inc. (MTI), with the support of The Pre-Mammogram ... developed a pre-commercial SureTouch™ Wireless system that ... According to a publication funded by ... were diagnosed with breast cancer in 2010 and 425,000 ... the best means to a good prognosis for breast ...
(Date:5/23/2012)... 2012   CryoLife, Inc. (NYSE: ... cardiac and vascular surgery, announced today that it will ... One-on-One Investor Conference on Thursday, May 31, 2012 in ... chief operating officer, and chief financial officer of CryoLife, ... conference will allow institutional investors to meet with the ...
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
Breaking Medicine Technology:Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 2Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 3Medical Tactile, Inc. Announces a 3G-Wireless System for Breast Cancer Screening 4CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference 2QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 1Rcadia Medical Imaging Awarded Four U S Patents Covering Technology for Automated Analysis of Coronary CT Angiography 18466 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 1Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 2Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 3Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 4Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 5Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 6Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed Dose Combination of PREZISTA AE and Cobicist 18463 7Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 1Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 2Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 3Morphotek AE Inc Announces Initiation of Farletuzumab Phase II Study in First Line Treatment of Non Small Cell Lung Cancer 18460 4
... NovaDel Pharma,Inc. (AMEX: NVD), a specialty pharmaceutical ... range of marketed treatments,today announced that its ... zolpidem tablets have met their primary,pharmacokinetic (PK), ... currently marketed as Ambien(R), a leading,drug for ...
... Oral Presentation Reports Significantly More Patients ... Least Three,Years, CHICAGO, June 04, 2007 ... (Taxotere plus,prednisone) maintained long-term efficacy as ... cancer patients,according to the three-year updated ...
Other Medicine Technology:NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: